Nukui M, Nakao M, Nakagawa S, Toyoda K, Takada H, Ebisui K, Watanabe H
Department of Urology, Kyoto Prefectural University of Medicine.
Hinyokika Kiyo. 1989 Sep;35(9):1497-501.
One hundred and eleven cases of bladder tumors were treated with transurethral resection (TUR) and transurethral electrocoagulation as the initial treatment from 1974 and 1983. Eighty nine cases were male and 22 cases were female. The average age was 60.1 years old. Of the 111 patients, 57, 33, 2, 1 and 15 patients had a tumor of Ta, T1, T2, T3a and Tx respectively. The number of grades G0, G1, G2, G3, GX cases was 1, 38, 40, 17, 12, respectively. Other than these, 2 cases of squamous cell carcinoma and 1 of adenocarcinoma were included. The actual survival rates for 5 years in Ta and T1 were 84.4 and 88.9% respectively, and the relative survival rates were 99.5 and 109.1%. TUR was recommended for superficial bladder tumor because of good prognosis. The 5-year recurrence rates for single tumors with and without prophylactic bladder instillation were 21.4 and 27.5% respectively, and those for multiple bladder tumors were 58.6 and 51.8%. There was no significant difference between the group with and without bladder instillation.
1974年至1983年期间，111例膀胱肿瘤患者接受了经尿道切除术（TUR）和经尿道电凝术作为初始治疗。其中男性89例，女性22例。平均年龄为60.1岁。111例患者中，分别有57例、33例、2例、1例和15例患有Ta、T1、T2、T3a和Tx期肿瘤。G0、G1、G2、G3、GX级病例数分别为1例、38例、40例、17例、12例。除此之外，还包括2例鳞状细胞癌和1例腺癌。Ta期和T1期的5年实际生存率分别为84.4%和88.9%，相对生存率分别为99.5%和109.1%。由于预后良好，推荐对浅表性膀胱肿瘤进行经尿道切除术。单发膀胱肿瘤在有和没有预防性膀胱灌注情况下的5年复发率分别为21.4%和27.5%，多发膀胱肿瘤的复发率分别为58.6%和51.8%。膀胱灌注组和未灌注组之间无显著差异。
